Search for a full or partial Catalog Number, CAS Number or description
CAS Number: 428514-91-4
Product Catalog
15-7115
Phosphorus › (R)-2-[(Diphenylphosphino)methyl]pyrrolidine, min. 97% (10 wt% in hexane)| CAS Number: | 428514-91-4 |
| MDL Number: | MFCD17013985 |
| Molecular Formula: | C17H20NP |
| Molecular Weight: | 269.32 |
| Chemical Formula: | C17H20NP |
| Color and Form: | colorless oil |
| Note: |
Stability: air sensitive
Safety: Hazardous
| SECTION 1: Product Identification | |
|---|---|
| Chemical Name: | (R)-2-[(Diphenylphosphino)methyl]pyrrolidine, min. 97% (10 wt% in hexane) |
| Product Number: | 15-7115 |
| CAS Registry Number: | 428514-91-4 |
| Formula: | C17H20NP |
| EINECS Number: | none |
| Chemical Family: | organophosphine ligand |
| Synonym: | (R)-2-[(Diphenylphosphano)methyl]pyrrolidine |
| SECTION 2: Composition and Information on Ingredients | ||||
|---|---|---|---|---|
| Ingredient | CAS Number | Percent | ACGIH (TWA) | OSHA (PEL) |
| Title compound | 428514-91-4 | 10 | no data | no data |
| Hexane | 110-54-3 | 90 | 50ppm | 1800mg/m3 |
| SECTION 3: Hazards Identification | |
|---|---|
| Emergency Overview: | Extremely flammable liquid. Vapors irritating to skin, eyes and respiratory tract. Inhalation of vapors may depress central nervous system causing dizziness, headache and nausea. |
| Primary Routes of Exposure: | Ingestion, inhalation, skin, eyes |
| Eye Contact: | Contact will cause irritation, redness and a burning sensation. |
| Skin Contact: | Contact with skin can result in local irritation. May be absorbed throuh skin. |
| Inhalation: | Inhalation of vapors may depress the central nervous system causing dizziness, difficulty in walking and irritation to the lungs. |
| Ingestion: | Ingestion may cause gastrointestinal irritation, nausea, vomiting and headache. May cause lung damage if swallowed. |
| Acute Health Effects: | Irritating to skin, eyes and respiratory tract. Harmful by inhalation. Ingestion may cause gastrointestinal irritation, nausea, vomiting and headache. Possible risk of harm to the unborn child. |
| Chronic Health Effects: | No information on long-term chronic effects. Possible risk of impaired fertility. |
| NTP: | No |
| IARC: | No |
| OSHA: | No |
| SECTION 4: First Aid Measures | |
|---|---|
| Eye Exposure: | Immediately flush the eyes with copious amounts of water for at least 10-15 minutes. A victim may need assistance in keeping their eye lids open. Get immediate medical attention. |
| Skin Exposure: | Wash the affected area with water. Remove contaminated clothes if necessary. Seek medical assistance if irritation persists. |
| Inhalation: | Remove the victim to fresh air. Closely monitor the victim for signs of respiratory problems, such as difficulty in breathing, coughing, wheezing, or pain. In such cases seek immediate medical assistance. |
| Ingestion: | Seek medical attention immediately. Keep the victim calm. Give the victim water (only if conscious). Induce vomiting only if directed by medical personnel. |
| SECTION 5: Fire Fighting Measures | |
|---|---|
| Flash Point: | -7°F |
| Autoignition Temperature: | no data |
| Explosion Limits: | LEL (1.7%) UEL (7.7%) |
| Extinguishing Medium: | carbon dioxide, dry powder or foam |
| Special Fire Fighting Procedures: | If this product is involved in a fire, fire fighters should be equipped with a NIOSH approved positive pressure self-contained breathing apparatus and full protective clothing. |
| Hazardous Combustion and Decomposion Products: | If involved in a fire this material may emit toxic and irritating fumes. |
| Unusual Fire or Explosion Hazards: | Extremely flammable |
| SECTION 6: Accidental Release Measures | |
|---|---|
| Spill and Leak Procedures: | If spilled, all personnel must be immediately evacuated and the area sealed off. The material may self-ignite releasing toxic and corrosive fumes of phosphorus pentoxide. Ventilation should be available. If entry into the area is requires, personnel should be fitted with a self-contained breathing apparatus. |
| SECTION 7: Handling and Storage | |
|---|---|
| Handling and Storage: | Store in a tightly sealed container under an inert atmosphere of nitrogen or argon. Keep away from heat. Material should be transferred under an inert atmosphere of nitrogen or argon in an efficient fume hood. |
| SECTION 8: Exposure Controls and Personal Protection | |
|---|---|
| Eye Protection: | Always wear approved safety glasses when handling a chemical substance in the laboratory. |
| Skin Protection: | Wear protective clothing and gloves. Consult with a glove manufacturer to determine the proper type of glove. |
| Ventilation: | Handle the material in an efficient fume hood. |
| Respirator: | If ventilation is not available a respirator should be worn. The use of respirators requires a Respirator Protection Program to be in compliance with 29 CFR 1910.134. |
| Additional Protection: | No additional protection required. |
| SECTION 9: Physical and Chemical Properties | |
|---|---|
| Color and Form: | colorless liquid |
| Molecular Weight: | 269.32 |
| Melting Point: | no data |
| Boiling Point: | 68°C (hexane) |
| Vapor Pressure: | no data |
| Specific Gravity: | no data |
| Odor: | pungent and noxious |
| Solubility in Water: | Insoluble |
| SECTION 10: Stability and Reactivity | |
|---|---|
| Stability: | air sensitive |
| Hazardous Polymerization: | no hazardous polymerization |
| Conditions to Avoid: | contact with oxidizing agents, ignition sources and prolonged exposure to air |
| Incompatibility: | strong oxidizing agents and halogens |
| Decomposition Products: | carbon monoxide, carbon dioxide, phosphorous pentoxide and organic fumes |
| SECTION 11: Toxicological Information | |
|---|---|
| RTECS Data: | No information available on title compound. For hexane -- Standard Draize Test (rabbit); 10mg (mild). Inhalation (human); TCLo: 190ppm/8W. Oral (rat); LD50: 28710mg/kg. Inhalation (rat); LC50: 48000ppm/4H. Intraperitoneal (rat); LDLo: 9100mg/kg. Intravenous (mouse); LDLo: 831mg/kg. Inhalation (rat); TCLo: 2000ppm/12H/24W-I. Acts a general anesthetic, respiratory depression, altered sleep time, effects on nerves, decreased weight gain, muscle weakness, and changes to the liver and blood. Toxic effects observed in the embryo and fetus of test animals. |
| Carcinogenic Effects: | No data |
| Mutagenic Effects: | For hexane: Possible mutagen |
| Tetratogenic Effects: | For hexane: Possible reproductive effector |
| SECTION 12: Ecological Information | |
|---|---|
| Ecological Information: | Toxic to aquatic organisms. May cause long-term adverse effects in the aquatic environment. |
| SECTION 13: Disposal Considerations | |
|---|---|
| Disposal: | Dispose of according to local, state and federal regulations. |
| SECTION 14: Transportation | |
|---|---|
| Shipping Name (CFR): | Flammable liquids, N.O.S. |
| Hazard Class (CFR): | 3 |
| Additional Hazard Class (CFR): | NA |
| Packaging Group (CFR): | I |
| UN ID Number (CFR): | UN# 1993 |
| Shipping Name (IATA): | Flammable liquid, N.O.S. |
| Hazard Class (IATA): | 3 |
| Additional Hazard Class (IATA): | NA |
| Packaging Group (IATA): | I |
| UN ID Number (IATA): | UN# 1993 |
| SECTION 15: Regulatory Information | |
|---|---|
| TSCA: | Not listed in the TSCA inventory |
| SARA (Title 313): | Not reportable under SARA 313 |
| Second Ingredient: | Listed on the TSCA inventory. Reportable under SARA 313. |
| Third Ingredient: | none |
| SECTION 16: Other Information | |
|---|---|
| Disclaimer: | The information herein is believed to be accurate and reliable as of the date compiled. However, Strem Chemicals, Inc. makes no representation, warranty, or guarantee of any kind with respect to the information contained in this document or any use of the product based on this information. |
| Preparation Date: | 1/11/2012 |
| Revision Date: | 4/06/2012 |
